官方服务：
资源简介：
Market share of generic drugs in France from 2008 to 2022
应用场景：
相关数据集
Replication data for: When Discounts Raise Costs: The Effect of Copay Coupons on Generic Utilization
Branded pharmaceutical manufacturers frequently offer "copay coupons" that insulate consumers from cost-sharing, thereby undermining insurers' ability to influence drug utilization. We study the impac
ICPSR2017-01-01 更新50
Procurement prices for originator brands and lowest priced generics medicine.
Procurement prices for originator brands and lowest priced generics medicine.
NIAID Data Ecosystem40
Perverse Reverse Price Competition: Average Wholesale Prices and Medicaid Pharmaceutical Spending
Generic drugs comprise an increasing share of total prescriptions dispensed in the U.S., rising from nearly 50 percent in 1999 to 75 percent in 2009. The generic drug market has typically been viewed
NBER2013-08-01 更新30
Replication data for: Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration
This paper develops a new approach to testing for strategic entry deterrence and applies it to the behavior of pharmaceutical incumbents before patent expiration. It examines a cross section of market
ICPSR2011-01-01 更新40
Branded Generics Market Size Worth $410.86 Billion By 2032 | CAGR: 5.60%
Global Branded Generics Market is anticipated to grow at a CAGR of 5.60% during the forecast period, with an estimated size and share exceeding USD 410.86 billion by 2032, according to projections.
www.polarismarketresearch.com2024-09-13 更新40
